These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27437879)

  • 1. The US Food and Drug Administration 515 Program Initiative: Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices?
    Rathi VK; Kesselheim AS; Ross JS
    JAMA Cardiol; 2016 May; 1(2):117-8. PubMed ID: 27437879
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical devices; reclassification of six cardiovascular preamendments class III devices into class II. Final rule.
    Food and Drug Administration
    Fed Regist; 2001 Apr; 66(69):18540-2. PubMed ID: 11721689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's perspectives on cardiovascular devices.
    Chen EA; Patel-Raman SM; O'Callaghan K; Hillebrenner MG
    J Cardiovasc Transl Res; 2009 Jun; 2(2):143-6. PubMed ID: 20559979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cardiac devices--an FDA pediatrician's perspective of the challenges and potential solutions.
    Dolcimascolo F
    J Cardiovasc Transl Res; 2009 Jun; 2(2):147-9. PubMed ID: 20559980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: medical devices.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-38. PubMed ID: 22403842
    [No Abstract]   [Full Text] [Related]  

  • 6. United States laws under review.
    Leahey M
    Med Device Technol; 2007; 18(3):44-5. PubMed ID: 17585722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The US Food and Drug Administration investigational device exemptions and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):115-22. PubMed ID: 10082096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The US Food and Drug Administration investigational device exemptions (IDE) and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Surg; 1999 Mar; 29(3):566-74. PubMed ID: 10069924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021.
    Wunnava S; Miller TA; Narang C; Nathan M; Bourgeois FT
    JAMA; 2022 Aug; 328(6):580-582. PubMed ID: 35943478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Devices; Cardiovascular Devices; Classification of the Esophageal Thermal Regulation Device. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Aug; 80(159):49895-7. PubMed ID: 26292372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: medical devices. Year end issue brief.
    Tiffany S
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
    [No Abstract]   [Full Text] [Related]  

  • 13. Food and Drug Administration Efforts to Mitigate Contact Lens Discomfort.
    Hampton D; Green JA; Robboy M; Eydelman M
    Eye Contact Lens; 2017 Jan; 43(1):2-4. PubMed ID: 27941360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; physical medicine devices; classification of the nonpowered lower extremity pressure wrap. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Jul; 79(128):37948-50. PubMed ID: 25016621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways to approval of pediatric cardiac devices in the United States: challenges and solutions.
    Beekman RH; Duncan BW; Hagler DJ; Jones TK; Kugler JD; Moore JW; Jenkins KJ;
    Pediatrics; 2009 Jul; 124(1):e155-62. PubMed ID: 19564262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devices and the food and drug administration.
    Phillips SJ; Phillips RS
    Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical Devices; Cardiovascular Devices; Classification of the Coronary Vascular Physiologic Simulation Software Device. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Oct; 80(203):63671-4. PubMed ID: 26495515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA regulation of cardiovascular devices and opportunities for improvement.
    Dhruva SS; Redberg RF
    J Interv Card Electrophysiol; 2013 Mar; 36(2):99-105. PubMed ID: 23263896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective date of requirement for premarket approval for three class III preamendments devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Aug; 76(158):50663-7. PubMed ID: 21845785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular, orthopedic, and physical medicine diagnostic devices; reclassification of cardiopulmonary bypass accessory equipment, goniometer device, and electrode cable devices. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(70):19317-9. PubMed ID: 11010630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.